1. Disease risk estimates in V30M variant transthyretin amyloidosis (A-ATTRv) from Mallorca.
- Author
-
Cisneros-Barroso, E., Gorram, F., Ribot-Sansó, M. A., Alarcon, F., Nuel, G., González-Moreno, J., Rodríguez, A., Hernandez-Rodriguez, J., Amengual-Cladera, E., Martínez-López, I., Ripoll-Vera, T., Losada-López, I., Heine-Suñer, D., and Plante-Bordeneuve, V.
- Subjects
TRANSTHYRETIN ,AMYLOIDOSIS ,GENETIC variation ,NONPARAMETRIC estimation ,AGE of onset ,BRUGADA syndrome - Abstract
Background: Variant transthyretin amyloidosis (A-ATTRv) is an autosomal dominant disease caused by a range of TTR gene variants which entail great phenotypical heterogeneity and penetrance. In Majorca, the A-ATTRv caused by the V30M gene variant (A-ATTRV30M) is the most common. Since asymptomatic carriers are at risk of developing the disease, estimating age of onset is vital for proper management and follow-up. Thus, the aim of this study was to estimate age-related penetrance in ATTRV30M variant carriers from Majorca. Methods: The disease risk among carriers from ATTRV30M families from Majorca was estimated by Non-parametric survival estimation. Factors potentially involved in the disease expression, namely gender and parent of origin were also analysed. Results: A total of 48 heterozygous ATTRV30M families (147 affected patients and 123 were asymptomatic carriers) were included in the analysis. Penetrance progressively increased from 6% at 30 years to 75% at 90 years of age. In contrast to other European populations, we observe a similar risk for both males and females, and no difference of risk according to the parent of origin. Conclusions: In this first study assessing the age-related penetrance of ATTRV30M variant in Majorcan families, no effect of gender or parent of origin was observed. These findings will be helpful for improving management and follow-up of TTR variant carrier individuals. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF